ULTRAPAR PARTICIPAÇÕES S.A. 1Q21 Earnings Conference Call 05.06.2021 Disclaimer Forward-looking statements ✓ This document may include "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "outlook," "project" and other similar expressions that predict or indicate future events or trend ...

Financial Data and Key Metrics Changes - The company's EBITDA reached R$996 million in Q1 2021, representing a 13% increase compared to Q1 2020. Excluding non-recurring tax credits from the previous year, recurring EBITDA grew by 23% [14][15] - Net income was 19% lower than in Q1 2020, primarily due to non-recurring tax credits and negative mark-to-market effects from foreign exchange hedging instruments [15][16] - The company maintained a net debt of R$11.9 billion, with leverage increasing from 3x to 3.3x net debt-to-EBITDA [19][20] Business Line Data and Key Metrics Changes - **Ultragaz**: EBITDA was R$150 million, a 2% growth year-over-year, despite a 4% decrease in sales volume [22][23] - **Ultracargo**: Achieved record EBITDA of R$93 million, a 2% increase from Q1 2020, with net revenues totaling R$172 million, up 5% [25][26] - **Oxiteno**: Recorded EBITDA of R$227 million, an 87% increase over the recurring EBITDA in Q1 2020, driven by an improved sales mix [31] - **Ipiranga**: EBITDA totaled R$563 million, a 17% increase from Q1 2020, despite a 2% decrease in sales volume [35] - **Extrafarma**: EBITDA grew by 30% to R$12 million, despite a 1% decline in gross revenues [40] Market Data and Key Metrics Changes - Ultragaz experienced a decrease in sales volume, particularly in the bottled segment, due to increased demand during the pandemic in the previous year [21] - Oxiteno's U.S. operations were impacted by severe weather, but overall sales volume remained flat year-over-year [28] - Ipiranga's sales volume decreased by 2%, with a notable drop in auto cycle volume due to pandemic restrictions [32] Company Strategy and Development Direction - The company aims to rationalize its portfolio and expects to achieve a leverage range of 2 to 2.5 times EBITDA by the end of the year [10] - Ongoing negotiations with Petrobras for the acquisition of Refap are progressing without interruption, with expectations to sign the purchase agreement soon [11] - The company is focusing on its ESG agenda, with plans to define and disclose ESG goals for 2030 by the end of the year [12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the operational performance despite the pandemic's challenges, highlighting the resilience of the portfolio [4][5] - The company anticipates a gradual decline in leverage throughout the year and expects to continue reaping benefits from investments made in previous years [10][14] - Management acknowledged the impact of external factors, such as exchange rates and commodity prices, on financial results but remains confident in the long-term strategy [16][19] Other Important Information - The company has implemented a restructuring of Ipiranga's commercial area, appointing a new Commercial Vice President to enhance operations [7] - The impact of a cyberattack on Extrafarma's operations was noted, with an estimated revenue loss of R$25 million, but recovery is expected through insurance [39][41] Q&A Session Summary Question: Fuel export expectations and refinery acquisition - Management noted a narrow window for gasoline exports in Q1 and stable conditions for diesel, with ongoing monitoring of internal prices compared to imports [46] Question: Oxiteno's performance and Texas plant operations - Management indicated a positive outlook for Oxiteno despite the Texas plant's temporary closure due to weather, with overall performance remaining strong [47] Question: Investment expectations in the petrochemical sector - Management emphasized the importance of capital allocation and the potential for future investments, but no specific decisions were disclosed [51] Question: Ipiranga's volume recovery and inventory effects - Management clarified that a cyberattack had minimal impact on Ipiranga's operations, and inventory management strategies were effectively implemented [53][55] Question: Oxiteno's margin progress and strategic refinery acquisition - Management confirmed ongoing negotiations for the refinery acquisition, with no interruptions due to leadership changes at Petrobras [61][62] Question: Expansion plans for convenience stores - Management outlined plans for expanding AmPm stores, with a focus on improving profitability and operational efficiency [86][88]

As filed with the Securities and Exchange Commission on April 29, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark one) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPO ...

Ultrapar Participacoes SA (NYSE:UGP) Q4 2020 Earnings Conference Call February 25, 2021 9:00 AM ET Company Participants Frederico Curado - CEO Rodrigo Pizzinatto - Chief Financial & IR Officer Conference Call Participants Thiago Duarte - BTG Pactual Andre Hachem - Itaú Regis Cardoso - Crédit Suisse Operator Good morning, ladies and gentlemen. At this time, we would like to welcome everyone to Ultrapar's Fourth Quarter 2020 Results Conference Call. There is also a simultaneous webcast that may be accessed th ...

Financial Data and Key Metrics Changes - In Q3 2020, Ultrapar's net revenues were BRL 21 billion, an 11% decrease compared to Q3 2019, primarily due to lower revenues at Ipiranga [28] - EBITDA amounted to BRL 1,038 million, a 6% increase year-on-year, or 5% growth excluding nonrecurring items [28] - Net income was BRL 277 million, a 10% decrease from the same quarter last year, mainly due to higher depreciation and amortization costs despite EBITDA growth [28][30] Business Line Data and Key Metrics Changes - **Ultragaz**: Sales volume fell 1% year-on-year, with bulk segment volumes growing by 1% and EBITDA reaching a record BRL 222 million, an 18% increase from Q3 2019 [13][14] - **Ultracargo**: Average capacity increased by 11% year-on-year, cubic meters sold rose by 14%, and net revenues were BRL 160 million, an 18% increase from Q3 2019 [15][17] - **Oxiteno**: Specialty chemicals volume rose 8% year-on-year, with EBITDA growing by 110% to BRL 169 million, driven by higher sales volume and real devaluation [19][20] - **Ipiranga**: Sales volume dropped 11% year-on-year, with EBITDA at BRL 566 million, a 17% decrease compared to last year but an increase from Q2 2020 [21][23] - **Extrafarma**: Gross revenues were BRL 523 million, a 3% decrease year-on-year, but EBITDA reached BRL 28 million, a record since acquisition, reflecting a 52% increase from Q3 2019 [26][27] Market Data and Key Metrics Changes - The economic recovery in Brazil positively influenced sales across various segments, particularly in bulk and industrial sectors [5][8] - Ipiranga's network ended the quarter with 7,107 service stations, with a focus on higher throughput stations to grow volumes [21][25] Company Strategy and Development Direction - The company is focused on analyzing refining assets that Petrobras intends to sell and expanding its new business, Abastece Ai, which has already accumulated 1.8 million active digital accounts [9][10] - Strategic personnel changes include the appointment of a new CFO and CEO for Extrafarma, aimed at enhancing operational efficiency and profitability [10][11] Management's Comments on Operating Environment and Future Outlook - Management noted a recovery in economic activity and expressed confidence in the resilience of Ultrapar's portfolio, with expectations for continued growth in the fourth quarter despite seasonal weaknesses [5][9] - The company aims to maintain financial discipline while pursuing growth opportunities, including potential partnerships for refinery acquisitions [41][70] Other Important Information - The company reported a cash position of BRL 9.8 billion, supported by strong operational cash generation and new funding [31][32] - CapEx was slightly above EUR 1 billion year-to-date, reflecting a 5% decrease compared to the same period in 2019, with a focus on cash preservation [29] Q&A Session Summary Question: How does the new board member contribute to capital allocation? - Management emphasized the importance of governance and the positive impact of the new board member's experience on capital allocation strategies [35][38] Question: What is the strategy regarding Petrobras' privatizations and natural gas? - Management indicated a desire for strategic partnerships in bidding for refineries but also expressed confidence in executing independently if necessary [36][41] Question: What is the outlook for Ipiranga's volumes and margins? - Management acknowledged a gradual recovery in sales volumes and a focus on defending their network, with expectations for continued improvement [43][44] Question: Can you elaborate on the CBIO provision and its impact on Ipiranga's results? - Management clarified that the BRL 66 million provision was primarily for the current year's CBIOs, with expectations for further adjustments in Q4 [46][48] Question: What are the future plans for Extrafarma and its profitability? - Management highlighted ongoing operational improvements and a focus on digital strategies to enhance profitability, with no immediate plans for divestiture [77]

ULTRA ULTRAPAR PARTICIPAÇÕES S.A. 3Q20 Earnings Conference Call 11.05.2020 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |------------|----------------------------|--------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------ ...

Ultrapar Participações S.A. (NYSE:UGP) Q2 2020 Earnings Conference Call August 13, 2020 11:45 AM ET Company Participants Frederico Curado – Chief Executive Officer André Pires – Chief Financial and Investor Relations Officer Conference Call Participants Frank McGann – BOA Operator Good morning, ladies and gentlemen. At this time, I would like to welcome everyone to Ultrapar's 2Q '20 Results Conference Call. There is also a simultaneous webcast that may be accessed through UltraparÂ's website at ri.ultra.com ...

Ultrapar Participações S.A. (NYSE:UGP) Q1 2020 Results Conference Call May 14, 2020 11:30 AM ET Company Participants Fred Curado - CEO Andre Pires - Chief Financial and IR Officer Conference Call Participants Christian Audi - Santander Frank McGann - Bank of America Luiz Carvalho - Banco UBS Operator Good morning, ladies and gentlemen. At this time, we would like to welcome everyone to Ultrapar's First Quarter 2020 Results Conference Call. There is also a simultaneous webcast that may be accessed through Ul ...

ULTRAPAR PARTICIPAÇÕES S.A. Earnings Conference Call – 1Q20 05.14.2020 Disclaimer Forward-looking statements ✓ This document may include "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "anticipate," "believe," "expect," "estimate," "plan," "outlook," "project" and other similar expressions that predict or indicate future events or tre ...

Table of Contents As filed with the Securities and Exchange Commission on May 4, 2020 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark one) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHE ...